STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Disease type (Chlamydia, Genital herpes, Gonorrhea), Product Type, Settings, End-user - Global Forecast 2024-2030

STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Disease type (Chlamydia, Genital herpes, Gonorrhea), Product Type, Settings, End-user - Global Forecast 2024-2030


The STD Testing Market size was estimated at USD 94.41 billion in 2023 and expected to reach USD 99.74 billion in 2024, at a CAGR 5.90% to reach USD 141.12 billion by 2030.

Global STD Testing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the STD Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the STD Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Access Medical Laboratories Inc., ARCpoint Labs, Bio-Rad Laboratories, Inc., bioMérieux SA, BioReference Health, LLC, Bristol Myers Squibb, DiaSorin S.p.A., Everlywell, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., Laboratory Corporation of America Holdings, OraSure Technologies, Inc., Personalabs, Planned Parenthood Federation of America Inc., PlushCare, Inc., Private MD Labs, Quest Consumer Inc., Thermo Fisher Scientific Inc., and Walgreen Co..

Market Segmentation & Coverage



This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Blood Tests
Lumbar Puncture
Swab Tests
Urine Tests
Disease type
Chlamydia
Genital herpes
Gonorrhea
Hepatitis B
HIV/AIDS
Human Papillomavirus (HPV)
Syphilis
Product Type
Instruments
Reagents & Kits
Settings
Laboratory
Point of Care
End-user
Diagnostic Centers
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the STD Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the STD Testing Market?
3. What are the technology trends and regulatory frameworks in the STD Testing Market?
4. What is the market share of the leading vendors in the STD Testing Market?
5. Which modes and strategic moves are suitable for entering the STD Testing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. STD Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
5.1.1.2. Increasing awareness about STDs through education campaigns
5.1.2. Restraints
5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
5.1.3. Opportunities
5.1.3.1. Ongoing technical advancements in STD disease diagnostics
5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
5.1.4. Challenges
5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. STD Testing Market, by Type
6.1. Introduction
6.2. Blood Tests
6.3. Lumbar Puncture
6.4. Swab Tests
6.5. Urine Tests
7. STD Testing Market, by Disease type
7.1. Introduction
7.2. Chlamydia
7.3. Genital herpes
7.4. Gonorrhea
7.5. Hepatitis B
7.6. HIV/AIDS
7.7. Human Papillomavirus (HPV)
7.8. Syphilis
8. STD Testing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.3. Reagents & Kits
9. STD Testing Market, by Settings
9.1. Introduction
9.2. Laboratory
9.3. Point of Care
10. STD Testing Market, by End-user
10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals & Clinics
11. Americas STD Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific STD Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa STD Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Access Medical Laboratories Inc.
15.1.3. ARCpoint Labs
15.1.4. Bio-Rad Laboratories, Inc.
15.1.5. bioMérieux SA
15.1.6. BioReference Health, LLC
15.1.7. Bristol Myers Squibb
15.1.8. DiaSorin S.p.A.
15.1.9. Everlywell, Inc.
15.1.10. F. Hoffmann-La Roche Ltd
15.1.11. Hologic, Inc.
15.1.12. Laboratory Corporation of America Holdings
15.1.13. OraSure Technologies, Inc.
15.1.14. Personalabs
15.1.15. Planned Parenthood Federation of America Inc.
15.1.16. PlushCare, Inc.
15.1.17. Private MD Labs
15.1.18. Quest Consumer Inc.
15.1.19. Thermo Fisher Scientific Inc.
15.1.20. Walgreen Co.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. STD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. STD TESTING MARKET DYNAMICS
FIGURE 7. STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. STD TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 10. STD TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 12. STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. STD TESTING MARKET SIZE, BY SETTINGS, 2023 VS 2030 (%)
FIGURE 14. STD TESTING MARKET SIZE, BY SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings